Chronic Hepatitis C in childhood: An 18-year experience

Clinical Infectious Diseases

Volumn 41, Issue 10, 2005, Pages 1431-1437

  Iorio, Raffaele ^a   Giannattasio, Antonietta ^a   Sepe, Angela ^a   Terraccianio, Luigi Maria ^a   Vecchione, Raffaella ^a   Vegnente, Angela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; HEPATITIS C ANTIBODY; MICROSOME ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; SMOOTH MUSCLE ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIREMIA;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; LONGITUDINAL STUDIES; MALE; TIME FACTORS; TREATMENT OUTCOME; VIREMIA;

EID: 27644505668     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/497141     Document Type: Article

References (34)

1. Alberti A, Benvegnu L, Boccato S, Ferrari A, Sebastiani G. Natural history of initially mild chronic hepatitis C. Dig Liver Dis 2004; 36:646-54.
2. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003; 36:275-80.
3. Guido M, Rugge M, Jara P, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998; 115:1525-9.
4. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004; 39:90-6.
5. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341:866-70.
6. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997; 90:4628-33.
7. Kage M, Fujisawa T, Shiraki K, et al. Pathology of chronic hepatitis C in children: child liver study group of Japan. Hepatology 1997; 26:771-5.
8. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28:1416-23.
9. Birnbaum AH, Shneider BL, Moy L. Hepatitis C in children. N Engl J Med 2000; 342:290-1.
10. Zancan L, Strafella MS, Brugiolo A, Malusa T, d'Amore ES. Chronic hepatitis C virus infection in childhood and early cirrhosis: it is possible? J Pediatr Gastroenterol Nutr 2000; 30:350-1.
11. Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002; 34:52-8.
12. Hartman C, Berkowitz D, Rimon N, Shamir R. The effect of early treatment in children with chronic hepatitis. J Pediatr Gastroenterol Nutr 2003; 37:252-7.
13. Lackner H, Moser A, Deutsch J, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000; 106:E53.
14. Suoglu D OD, Elkabes B, Sokucu S, Saner G. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C? J Pediatr Gastroenterol Nutr 2002; 34:199-20.6
15. Wirth S, Lang T, Gehring S, Gerner P. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002; 36:1280-4.
16. Iorio R, Pensati P, Botta S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997; 16:984-90.
17. Bortolotti F, Vajro P, Barbera C, et al. Patterns of antibodies to hepatitis C virus and hepatitis C virus replication in children with chronic non-A, non-B hepatitis. J Pediatr 1994; 125:916-8.
18. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts: United States Adv Data. 314:1-27. Available at: http://www.cdc.gov/nccdphp/dnpa/ growthcharts/sas.htm. Accessed 30 September 2005.
19. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-9.
20. Detmer J, Lagier R, Flynn J, et al. Accurate quantification of HCV-RNA from all HCV genotypes using branched DNA (b-DNA) technology. J Clin Microbiol 1996; 34:901-7.
21. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74:661-8.
22. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-38.
23. Iorio R, Giannattasio A, Vespere G, Vegnente A. LKM1 antibody and interferon therapy in children with chronic hepatitis C. J Hepatol 2001; 35:685-7.
24. Iorio R, Spagnuolo MI, Sepe A, Zoccali S, Alessio M, Vegnente A. Severe Raynaud's phenomenon with chronic hepatis C disease treated with interferon. Pediatr Infect Dis J 2003; 22:195-7.
25. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33:106-15.
26. Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002; 36:5179-84.
27. Mochida S, Hashimoto M, Matsui A, et al. Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Biochem Biophys Res Commun 2004; 313:1079-85.
28. Hervé S, Savoye G, Riachi G, et al. Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity? Eur J Gastroenterol Hepatol 2001; 13:495-500.
29. Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol 2003; 98:1588-93.
30. Jacobson IM, Ahmed F, Russo MW, et al. Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol 2004; 99:1700-5.
31. Bortolotti F, Muratori L, Jara P, et al. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr 2003; 142:185-90.
32. Guido M, Bortolotti F, Leandro G, et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003; 98:660-3.
33. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. American Association for the Study of Liver Diseases. Hepatology 2004; 39:1147-71.
34. Lo Nigro L, La Spina M, Mirabile E, Pisana P, Schiliro G, Guardo P. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL. Pediatr Blood Cancer 2004; 43:185.